Edinan, Jessel .
HRN: 23-36-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
CEFUROXIME 500MG (TAB)
07/21/2023
07/28/2023
PO
500mg
BID X 7 Days
S/P NSVD With Perineorrhaphy; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes